Atika Capital Management LLC Edwards Lifesciences Corp Transaction History

Atika Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $2.39 Million - $3.11 Million	29,000 New	29,000 $2.4 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $733,740 - $1.13 Million	-14,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$71.7 - $82.09 $430,200 - $492,540	6,000 Added 75.0%	14,000 $3.27 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $492,400 - $603,440	8,000 New	8,000 $1.76 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Atika Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Atika Capital Management LLC with notifications on news.